Exercise Training in Patients After Bypass Surgery

Sponsor
Bezmialem Vakif University (Other)
Overall Status
Completed
CT.gov ID
NCT05188352
Collaborator
(none)
30
2
17.9

Study Details

Study Description

Brief Summary

Based on clinical experience both physical condition and psychological recovery after surgery are individually variable. Exercise training plays an important part, has been recommended for CABS patients in order to enhance recovery. Regular exercise following CABS has shown that, in addition to the expected improvements in exercise capacity as a result of the surgery itself, patients who participate in cardiac rehabilitation can expect to see additional gains in exercise capacity and risk factor profiles. Exercise training also increases personal self-esteem and self-confidence, can alleviate depression and fear, and increase the sense of well-being. The aim of this study was to examine the effects of supervised aerobic exercise training on pulmonary function, functional capacity, maximal exercise capacity, and anxiety in patients after coronary artery bypass surgery.

Condition or Disease Intervention/Treatment Phase
  • Other: Chest physiotherapy
  • Other: Aerobic exercise training
N/A

Detailed Description

Patients in the training group received supervised aerobic exercise training on the treadmill with the intensity of 60-75% of maximal VO2 for 40-50 minutes, 3 days a week for 8 weeks in a cardiac rehabilitation unit. Work-load was gradually increased during eight-week period. Each session had a five-minute warm-up and cool-down period. Blood pressure and ECG were recorded during training sessions before exercise, at the third minute of each workload, after exercise, and during each minute of the recovery period. In addition, conventional chest physiotherapy and was instructed to continue their daily physical activity program at home patients in this group Patients in the control group received no aerobic exercise training but were asked to continue their chest physiotherapy and daily physical activity program at home.

The same researcher, who was blind to the group allocation, were evaluated all patients for pulmonary functions, respiratory muscle strength and submaximal functional capacity, exercise capacity, and anxiety level initially and after 8 weeks.

Study Design

Study Type:
Interventional
Actual Enrollment :
30 participants
Allocation:
Randomized
Intervention Model:
Parallel Assignment
Masking:
Double (Participant, Outcomes Assessor)
Primary Purpose:
Treatment
Official Title:
Effects of Supervised Aerobic Exercise Training on Respiratory Parameters, Exercise Capacity, and Anxiety in Patients With Coronary Artery Bypass Surgery
Actual Study Start Date :
Jan 1, 2017
Actual Primary Completion Date :
Jun 1, 2018
Actual Study Completion Date :
Jul 1, 2018

Arms and Interventions

Arm Intervention/Treatment
Experimental: Training group

Patients in the training group received supervised aerobic exercise training on the treadmill with the intensity of 60-75% of maximal VO2 for 40-50 minutes, 3 days a week for 8 weeks. Work-load was gradually increased during the eight-week period. In addition, conventional chest physiotherapy and was instructed to continue their daily physical activity program at home patients in this group.

Other: Chest physiotherapy
The program included diaphragmatic breathing exercises, thoracic expansion exercises, incentive spirometer exercises, and coughing techniques.

Other: Aerobic exercise training
A treadmill was used for aerobic exercise. Training intensity was used at 60-75% of maximal VO2. Each session had a five-minute warm-up and cool-down period. Blood pressure and ECG were recorded during training sessions before exercise, at the third minute of each workload, after exercise, and during each minute of the recovery period.

Active Comparator: Control group

Patients in the control group received no aerobic exercise training but were asked to continue their chest physiotherapy and daily physical activity program at home.

Other: Chest physiotherapy
The program included diaphragmatic breathing exercises, thoracic expansion exercises, incentive spirometer exercises, and coughing techniques.

Outcome Measures

Primary Outcome Measures

  1. Change from baseline maximum inspiratory pressure at 8 weeks. [[ Time Frame: Eight weeks ]]

    Change from baseline Maximum Inspiratory Pressure (MIP) at 8 weeks. Respiratory muscle strength was measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MIP measurement is a non-invasive technique.

  2. Change from baseline maximum expiratory pressure at 8 weeks [[ Time Frame: Eight weeks ]]

    Change from baseline Maximum Expiratory Pressure (MEP) at 8 weeks. Respiratory muscle strength was measured according to the portable, electronic intraoral pressure measuring device (MicroRPM, Micro Medical UK), American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria. The most commonly used method for evaluating respiratory muscles is MEP measurement is a non-invasive technique.

  3. Maximal exercise capacity [[ Time Frame: Eight weeks ]]

    The incremantal, symptom-limited cardiopulmonary exercise test (CPET) was used to assess exercise capacity. Symptom-limited maximal exercise test with oxygen consumption measurement (peak VO2) (Minjhard Oxycon-3) on the treadmill using a Modified Bruce protocol.

Secondary Outcome Measures

  1. Change from baseline distance covered in six-minute walk test at 8 weeks. [[ Time Frame: Eight weeks ]]

    Change from baseline functional capacity test at 8 weeks. Functional capacity was assessed by the 6 minute walking test. The test was performed according to American Thoracic Society (ATS) criteria. Patients were allowed to rest for 10 minutes before the test. Heart rate, blood pressure, respiratory frequency, oxygen saturation, fatigue and dyspnea perception were recorded before and after the test. Walking distance was calculated.

  2. Change from baseline Forced Vital Capacity (FVC) at 8 weeks [[ Time Frame: Eight weeks ]]

    Change from baseline Forced Vital Capacity (FVC) in respiratory function test at 8 weeks. FVC was evaluated using spirometry, according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria.

  3. Change from baseline Forced Expiratory Volume in 1 second (FEV1) at 8 weeks . [[ Time Frame: Eight weeks ]]

    Change from baseline Forced Expiratory Volume 1 second (FEV1) in respiratory function at 8 weeks. FEV1 was evaluated using spirometry, according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria.

  4. Change from baseline Forced Expiratory flow from between 25% to 75% of Vital Capacity at 8 weeks. [[ Time Frame: Eight weeks ]]

    Change from baseline Forced Expiratory flow from between 25% to 75% of Vital Capacity at 8 weeks. FMF was evaluated using spirometry, according to the American Thoracic Society (ATS) and European Respiratory Society (ERS) criteria.

  5. Change from baseline anxiety level at 8 weeks. [[ Time Frame: Eight weeks ]]

    Anxiety level was evaluated by STAI-I and II.

  6. Change from baseline maximal oxygen consumption(VO2max) level at 8 weeks [[ Time Frame: Eight weeks ]]

    Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured.

  7. Change from baseline maximal respiratory minute volume (VE), level at 8 weeks [[ Time Frame: Eight weeks ]]

    Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured

  8. Change from baseline VO2max/kg level at 8 weeks [[ Time Frame: Eight weeks ]]

    Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured

  9. Change from baseline maximal oxygen pulse (O2pulse) level at 8 weeks [[ Time Frame: Eight weeks ]]

    O2 pulse value was calculated from VO2 value which was divided to (by) heart rate at that minute.

  10. Change from baseline maximal MET level at 8 weeks [[ Time Frame: Eight weeks ]]

    Respiratory parameters were continuously measured by using computerized 'Minjhard Oxycon-3'. Measurements were performed in each 30 second, before, during and after exercise test and during each recovery period for five minutes parameters measured

Eligibility Criteria

Criteria

Ages Eligible for Study:
35 Years to 70 Years
Sexes Eligible for Study:
Male
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Male gender,

  • CABG surgery performed in the last one month,

  • Patients with negative exercise test (on the 30 days after discharge).

Exclusion Criteria:
  • Valve surgery,

  • Perioperative myocardial infarction assessed by electrocardiographic (ECG) and creatine kinase isoenzyme changes,

  • Postoperative angina, diabetes mellitus, chronic renal failure, unstable angina, intermittent claudication, heart valve dysfunction (moderate or severe), severe cardiac arrhythmias, -Presence of symptoms at rest or with minimal exertion,

  • Chronic obstructive pulmonary disease (>70% FEV1/FVC), and

  • Any disorder that might influence exercise performance physically (e.g. severe back pain, history stroke).

Contacts and Locations

Locations

No locations specified.

Sponsors and Collaborators

  • Bezmialem Vakif University

Investigators

  • Study Chair: Semiramis Özyılmaz, Assoc. Prof., Bezmialem Vakif University

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
Bezmialem Vakif University
ClinicalTrials.gov Identifier:
NCT05188352
Other Study ID Numbers:
  • BVUsozyilmaz09
First Posted:
Jan 12, 2022
Last Update Posted:
Jan 12, 2022
Last Verified:
Dec 1, 2021
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by Bezmialem Vakif University

Study Results

No Results Posted as of Jan 12, 2022